As of 2025-09-18, the Relative Valuation of Harpoon Therapeutics Inc (HARP) is (12.44) USD. This relative valuation is based on P/E multiples. With the latest stock price at 23.01 USD, the upside of Harpoon Therapeutics Inc based on Relative Valuation is -154.0%.
The range of the Relative Valuation is (9.75) - (16.45) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.5x - 11.5x | 8.0x |
| Forward P/E multiples | 6.8x - 12.1x | 9.4x |
| Fair Price | (9.75) - (16.45) | (12.44) |
| Upside | -142.4% - -171.5% | -154.0% |
| Date | P/E |